Avita Medical
RCEL
Avita Medical (RCEL) - Cash on Hand
Cash on Hand as of March 2024 : $68.18 M
According to Avita Medical
's latest financial reports the company has $68.18 M in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Avita Medical - Cash on Hand chart (from 2020 to 2019)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $89.05 M | 12.24% |
| 2022-12-31 | $79.34 M | |
| 2021-06-30 | $0.11 B | 50.39% |
| 2020-06-30 | $73.63 M | 419.73% |
| 2019-06-30 | $14.16 M | 75.84% |
| 2018-06-30 | $8.05 M | 259.95% |
| 2017-06-30 | $2.23 M | -17.95% |
| 2016-06-30 | $2.72 M | 1772.14% |
| 2015-06-30 | $0.14 M | -95.49% |
| 2014-06-30 | $3.23 M | -63.43% |
| 2013-06-30 | $8.84 M | 2.56% |
| 2012-06-30 | $8.62 M | -40.72% |
| 2011-06-30 | $14.55 M | 400.5% |
| 2010-06-30 | $2.9 M | 15.24% |
| 2009-06-30 | $2.52 M | -68.95% |
| 2008-06-30 | $8.12 M | -9.44% |
| 2007-06-30 | $8.97 M | 89.77% |
| 2006-06-30 | $4.72 M | |
| 2004-06-30 | $1.68 M | |
| 2002-12-31 | $1.46 M | -44.61% |
| 2001-12-31 | $2.64 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Organovo ONVO | $2.9 M | -95.75% | 🇺🇸 USA |
 Orchard Therapeutics
ORTX | $0.12 B | 83.94% | 🇬🇧 UK |
 Novavax NVAX | $0.48 B | 604.85% | 🇺🇸 USA |
 Novocure
NVCR | $0.87 B | 1,176.19% | Jersey |